Last reviewed · How we verify
NCT06349330: 3D scanner
The Immediate Effectiveness of a 3D Intraoral Scanner as an Oral Hygiene Educational Tool
NA trial testing Test: 3D intra-oral scanner in Periodontal Diseases in 52 participants. Completed in 3 June 2024.
3 June 2024
Quick facts
| Lead sponsor | National University Hospital, Singapore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 52 |
| Start date | 7 November 2023 |
| Primary completion | 3 June 2024 |
| Estimated completion | 3 June 2024 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Test: 3D intra-oral scanner
- Control: Standard oral hygiene
Conditions studied
- Periodontal Diseases — all drugs for Periodontal Diseases →
- Plaque Induced Gingival Disease — all drugs for Plaque Induced Gingival Disease →
Sponsor
National University Hospital, Singapore
Who can join
Adults 21 to 75, any sex, with Periodontal Diseases or Plaque Induced Gingival Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized controlled clinical trial is to compare the immediate effectiveness of 3D intra-oral scanners and standard oral hygiene instructions in improving the oral hygiene of 52 subjects. The main question\[s\] it aims to answer are: * Does a 3D intra-oral scanner facilitate the improvement of oral hygiene in subjects? * Does a 3D-rendered image of plaque-stained teeth confer better visualization to subjects? Prospective Open Cohort study: Patients referred to NUCOHS Periodontology Department will be invited to participate in the study. Included participants will be randomized into the 3D scanner (test) and standard oral hygiene (control) group. Subsequently, both groups will receive personalized oral hygiene instructions before brushing their teeth. The participants will receive plaque disclosing again to compare the differences between baseline and post-intervention. Routine periodontal parameters will be recorded at baseline and researchers will compare the percentage improvement in full mouth plaque scores to see if the test group performed better than the control group. A questionnaire will be given to subjects in the test and control group for qualitative analysis. The study will require 1 visit.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Immediate Effects of a 3D Intraoral Scanner as an Adjunctive Oral Hygiene Educational Tool: A Randomised Controlled Trial.
Choo HJS, Xie JMJ, Lu XTJ, Lai WMC, et al · · 2026 · PMID 42143740 · DOI 10.1111/idh.70091
Verify or expand the search:
- PubMed search for NCT06349330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Periodontal Diseases
Currently open trials in the same condition.
- NCT07358104 — Efficacy of Camel Whey Protein and Camel Whey Protein Nanoparticles for Treating Intra-bony Periodontal Defects · NA · active not recruiting
- NCT07312045 — HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical T · recruiting
- NCT07384221 — Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients · recruiting
- NCT07530978 — ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE · recruiting
- NCT06848790 — Interdental Hygiene Methods in Young Adults · NA · recruiting
Other National University Hospital, Singapore trials
Trials by the same sponsor.
- NCT06027983 — Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors · Phase 1, PHASE2 · not yet recruiting
- NCT07460505 — Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure · NA · not yet recruiting
- NCT07319676 — Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas · Phase 1, PHASE2 · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07091175 — Dupilumab Therapy in Nephrotic Syndrome in Children · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06349330 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National University Hospital, Singapore
- Last refreshed: 17 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06349330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing